Seventh Annual Advances in Hematology and Oncology Fall Symposium
The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The Seventh Annual Advances in Hematology and Oncology Fall Symposium will update participants on symptom management, CAR-T Cell therapy, AML, gynecology oncology, breast surveillance/treatment options and more.
The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.
Target Audience
Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses
Learning Objectives
- Summarize current evidence-based practice guidelines for topic area presented.
- List currently available clinical trials that will benefit patients.
- Discuss the most current scientific and clinical research data and apply information to clinical practice.
AGENDA
6:45-7:45AM Breakfast/Viewing Exhibits
7:55-8:00AM Introduction | John Burfeind, MD
8:00-8:45 AM Endocrine Resistance in Hormone Positive Breast Cancer | Lubna Chaudhary, MD, MS
8:45-9:30AM Hot Cancer Clinical Trials | James P. Thomas, MD, PhD
9:30-9:45AM Break
9:45-10:30AM Breakout Sessions:
- AML Update 2018 | Ehab Atallah, MD
- Updates in Gynecology Oncology | Denise Uyer, MD
- High-Risk Breast Surveillance and Treatment Options | Kristi Caddock, ANP-BC, APNP
10:30-11:15AM Metastatic Melanoma: Where Have We Been & Where Are We Going | Amy Harker-Murray, MD
11:15-12:00PM Update on Renal Cell Carcinoma: New Frontiers for Research and Treatment | Sumanta Pal, MD
12:00-12:10PM Adjournment | John Burfeind, MD
12:10PM Lunch
Hyatt on Main and KI Convention Center
333 Main Street
Green Bay, WI 54301
A block of rooms have been set-aside for meeting attendees on Friday evening October 21st at the Hyatt on Main (Attached to the KI Center), at a special reate of $142 (single or double occupany). Reservations can be made by phone.
Phone Reservations: (888) 421-1442 Group Name: Medical College of Wisconsin
Complimentary parking is available for overnight Hyatt guests. Event attendees should park in the Washington Commons Main Street Parking Ramp, Attached to the KI Convention Center by a connecting skywalk.
Guest Speakers
Sumanta Kumar Pal, MD
Associate Clinical Professor
Department of Medical Oncology & Therapeutics Research
Co-Director, Kidney Cancer Program
City of Hope
Speakers
Ehab Atallah, MD
Associate Professor of Medicine
Medical College of Wisconsin
Kristi Caddock, ANP-BC, APNP
Medical College of Wisconsin
Lubna Chaudhary, MD, MS
Assistant Professor of Medicine
Medical College of Wisconsin
Amy Harker-Murray, MD
Assistant Professor of Medicine
Medical College of Wisconsin
James P. Thomas, MD, PhD
Professor of Medicine
Section Chief, Solid Tumor Oncology
Associate Director, Translational Research
Medical Director, Clinical Trials Office
Medical College of Wisconsin
Denise Uyar, MD, FACR, FASTRO
Chief, Gynecologic Oncology
Associate Professor of Gynecology and Obstetrics
Medical College of Wisconsin
Planning Committee
John Burfeind, MD, Program Director
David Groteluschen, MD
Anthony Jaslowski, MD, FACP
Wendy Peltier, MD
J. Douglas Rizzo, MD, MS
James Thomas, MD, PhD
Dan Bullock
All persons in control of content have NO relevant relationships to disclose with the exception of:
Name | Company | Relationship |
---|---|---|
John Burfeind, MD | Medical Logic, Inc. | Co-Founder |
In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.75 hours of participation for continuing education for allied health professionals.
Available Credit
- 3.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.50 Hours of ParticipationHours of Participation credit.